Citation
Garofalo, Maria, et al. "Alzheimer's, Parkinson's Disease and Amyotrophic Lateral Sclerosis Gene Expression Patterns Divergence Reveals Different Grade of RNA Metabolism Involvement." International Journal of Molecular Sciences, vol. 21, no. 24, 2020.
Garofalo M, Pandini C, Bordoni M, et al. Alzheimer's, Parkinson's Disease and Amyotrophic Lateral Sclerosis Gene Expression Patterns Divergence Reveals Different Grade of RNA Metabolism Involvement. Int J Mol Sci. 2020;21(24).
Garofalo, M., Pandini, C., Bordoni, M., Pansarasa, O., Rey, F., Costa, A., Minafra, B., Diamanti, L., Zucca, S., Carelli, S., Cereda, C., & Gagliardi, S. (2020). Alzheimer's, Parkinson's Disease and Amyotrophic Lateral Sclerosis Gene Expression Patterns Divergence Reveals Different Grade of RNA Metabolism Involvement. International Journal of Molecular Sciences, 21(24). https://doi.org/10.3390/ijms21249500
Garofalo M, et al. Alzheimer's, Parkinson's Disease and Amyotrophic Lateral Sclerosis Gene Expression Patterns Divergence Reveals Different Grade of RNA Metabolism Involvement. Int J Mol Sci. 2020 Dec 14;21(24) PubMed PMID: 33327559.
TY - JOUR
T1 - Alzheimer's, Parkinson's Disease and Amyotrophic Lateral Sclerosis Gene Expression Patterns Divergence Reveals Different Grade of RNA Metabolism Involvement.
AU - Garofalo,Maria,
AU - Pandini,Cecilia,
AU - Bordoni,Matteo,
AU - Pansarasa,Orietta,
AU - Rey,Federica,
AU - Costa,Alfredo,
AU - Minafra,Brigida,
AU - Diamanti,Luca,
AU - Zucca,Susanna,
AU - Carelli,Stephana,
AU - Cereda,Cristina,
AU - Gagliardi,Stella,
Y1 - 2020/12/14/
PY - 2020/11/06/received
PY - 2020/11/27/revised
PY - 2020/12/06/accepted
PY - 2020/12/17/entrez
PY - 2020/12/18/pubmed
PY - 2021/3/16/medline
KW - Alzheimer’s disease
KW - Parkinson’s disease
KW - amyotrophic lateral sclerosis
KW - gene expression
KW - long non-coding RNAs
JF - International journal of molecular sciences
JO - Int J Mol Sci
VL - 21
IS - 24
N2 - Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS) are neurodegenerative disorders characterized by a progressive degeneration of the central or peripheral nervous systems. A central role of the RNA metabolism has emerged in these diseases, concerning mRNAs processing and non-coding RNAs biogenesis. We aimed to identify possible common grounds or differences in the dysregulated pathways of AD, PD, and ALS. To do so, we performed RNA-seq analysis to investigate the deregulation of both coding and long non-coding RNAs (lncRNAs) in ALS, AD, and PD patients and controls (CTRL) in peripheral blood mononuclear cells (PBMCs). A total of 293 differentially expressed (DE) lncRNAs and 87 mRNAs were found in ALS patients. In AD patients a total of 23 DE genes emerged, 19 protein coding genes and four lncRNAs. Through Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) analyses, we found common affected pathways and biological processes in ALS and AD. In PD patients only five genes were found to be DE. Our data brought to light the importance of lncRNAs and mRNAs regulation in three principal neurodegenerative disorders, offering starting points for new investigations on deregulated pathogenic mechanisms.
SN - 1422-0067
UR - https://www.unboundmedicine.com/medline/citation/33327559/Alzheimer's_Parkinson's_Disease_and_Amyotrophic_Lateral_Sclerosis_Gene_Expression_Patterns_Divergence_Reveals_Different_Grade_of_RNA_Metabolism_Involvement_
DB - PRIME
DP - Unbound Medicine
ER -